𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory

✍ Scribed by Jérôme Gouttenoire; François Penin; Darius Moradpour


Book ID
104590700
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
334 KB
Volume
20
Category
Article
ISSN
1052-9276

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Hepatitis C virus (HCV) is a positive‐strand RNA virus that replicates its genome in a membrane‐associated replication complex. Nonstructural protein 4B (NS4B) induces the specific membrane alteration, designated as membranous web (MW), that harbours this complex. HCV NS4B is an integral membrane protein predicted to comprise four transmembrane segments in its central part. The N‐terminal part comprises two amphipathic α‐helices of which the second has the potential to traverse the membrane bilayer, likely upon oligomerisation. The C‐terminal part comprises a predicted highly conserved α‐helix, a membrane‐associated amphipathic α‐helix and two reported palmitoylation sites. NS4B interacts with other viral nonstructural proteins and has been reported to bind viral RNA. In addition, it was found to harbour an NTPase activity. Finally, NS4B has recently been found to have a role in viral assembly. Much work needs to be done with respect to further dissecting these multiple functions as well as providing a refined membrane topology and complete structure of NS4B. Progress in this direction should yield important insights into the functional architecture of the HCV replication complex and may reveal new opportunities for antiviral intervention against a leading cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma worldwide. Copyright © 2010 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Cyclosporine A inhibits hepatitis C viru
✍ Sandra Ciesek; Eike Steinmann; Heiner Wedemeyer; Michael P. Manns; Johann Neyts; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

Numerous anti-hepatitis C virus (HCV) drugs targeting either the viral nonstructural 3 (NS3) protease or NS5B polymerase are currently in clinical testing. However, rapid resistance development is a major problem and optimal therapy will clearly require a combination of multiple mechanisms of action

Sensitivity of hepatitis C virus to cycl
✍ Fiona Fernandes; Daniel S. Poole; Spencer Hoover; Rannveig Middleton; Adin-Crist 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 604 KB

HCV reoccurs after liver transplantation and increases mortality. Cyclosporine, but not tacrolimus, has potent antiviral effects against HCV replication in cell culture. To determine the conditions, if any, under which HCV is susceptible to cyclosporine in vivo, we selected for cyclosporine-resistan

Dual therapy with the nonstructural prot
✍ Kazuaki Chayama; Shoichi Takahashi; Joji Toyota; Yoshiyasu Karino; Kenji Ikeda; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 905 KB

The following corrections have since been made: ''BMS-790052'' has been replaced throughout with ''daclatasvir''; ''BMS-50032'' has been replaced throughout with ''asunaprevir''. The article has been updated online and in print.

Hepatitis C virus NS4A and NS4B proteins
✍ Jun Kato; Naoya Kato; Hideo Yoshida; Suzane Kioko Ono-Nita; Yasushi Shiratori; M 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

## Abstract Many viruses can inhibit protein synthesis in their host cells by targeting translation (“translational shutoff”). There are few reports on the effects of hepatitis C virus (HCV) infection on protein synthesis, because of the lack of a reproducible tissue culture system for HCV. In this

Apolipoprotein E interacts with hepatiti
✍ Wagane J. A. Benga; Sophie E. Krieger; Maria Dimitrova; Mirjam B. Zeisel; Marie 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 812 KB

Chronic hepatitis C virus (HCV) infection is a major cause of liver disease worldwide. Restriction of HCV infection to human hepatocytes suggests that liver-specific host factors play a role in the viral life cycle. Using a yeast-two-hybrid system, we identified apolipoprotein E (apoE) as a liver-de